Crescent Capital BDC, Inc. (NASDAQ:CCAP) Q1 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call highlights several concerns: declining net investment income, increased loans on non-accrual, and a higher debt-to-equity ratio. The Q&A reveals management's evasive responses on non-accrual assets and restructuring, indicating uncertainty. Despite consistent dividends, the lack of a share repurchase program and overall market pressure on spreads contribute to a negative sentiment. These factors suggest a negative stock price reaction in the short term.
Key Financial Performance
Net Investment Income (NII) $16.6 million ($0.45 per share) compared to $20.5 million ($0.55 per share) in the previous quarter, a decline driven by lower base rates, runoff of one-time non-recurring income, reduced dividend income from the Logan JV, and an increase in loans on non-accrual.
Loans on Non-Accrual Increased to 3.5% of debt investments at cost and 1.8% at fair value, attributed to one-off credit events at certain borrowers.
Gross Deployment Totaled $105 million, with 98% in first lien investments, compared to approximately $78 million in exits, resulting in net deployment of approximately $27 million.
Weighted Average Yield Decreased by 50 basis points quarter over quarter to 10.4%, reflecting changes in base rates.
Net Asset Value (NAV) per Share $19.62, with stockholders’ equity at $727 million.
Debt to Equity Ratio Increased from 1.19 times to 1.25 times, within the target leverage range of 1.1 to 1.3 times.
Weighted Average Interest Rate on Borrowings 6.36% as of quarter end, expected to decrease to 6.17% post-SPV facility amendment.
Regular Dividend Declared at $0.42 per share for Q2 2025, marking the 37th consecutive quarter of earning the regular dividend.
Special Dividend Second of three previously announced $0.05 per share special dividends related to undistributed taxable income, payable in June.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Gross Deployment: Gross deployment in the first quarter totaled $105 million, of which 98% was in first lien investments.
Investment Opportunities: Despite tariff announcements, attractive investment opportunities were identified that fit the core investment mandate.
Portfolio Characteristics: The portfolio ended the quarter with over $1.6 billion of investments across 191 companies, with 91% in first lien loans.
Net Investment Income: Net investment income for Q1 2025 was $16.6 million, down from $20.5 million in Q4 2024.
Loans on Non-Accrual: Loans on non-accrual increased to 3.5% of debt investments at cost.
Dividend Declaration: A regular dividend of $0.42 per share was declared for Q2 2025.
SPV Facility Resizing: Rightsized SPV asset facility from $500 million to $400 million, reducing the spread by 50 basis points.
Focus on Non-Cyclical Industries: Investment efforts are focused on non-cyclical industries diversified across 20 broad categories.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Net Investment Income Decline: Net investment income decreased from $20.5 million to $16.6 million, primarily due to lower base rates from FOMC rate cuts, the roll-off of non-recurring items, and reduced dividend income from the Logan JV.
Increase in Non-Accrual Loans: Loans on non-accrual increased to 3.5% of debt investments, indicating potential credit risk, although these represent less than 1.2% of the total portfolio.
Market Volatility and Tariff Impact: Tariff announcements have led to a cautious approach from sponsors regarding new platform activity, contributing to a backlog in deal activity.
Economic Factors: The company faces challenges from changes in base rates affecting net investment income, with a lag in the impact on floating rate liabilities.
Portfolio Diversification Risks: Despite a diversified portfolio, the company remains exposed to one-off credit events that could impact investment income and net asset value.
Debt Management: The company’s debt to equity ratio increased to 1.25 times, which is within the target range but indicates reliance on leverage.
Regulatory and Market Conditions: The overall economic environment and regulatory changes, including tariffs, may affect the performance and stability of the investment portfolio.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Investment Portfolio: Crescent Capital BDC ended the quarter with over $1.6 billion of investments at fair value across a diversified portfolio of 191 companies, focusing on first lien loans which represent 91% of the portfolio.
Market Positioning: The company is maintaining selectivity in its investment approach, particularly in light of recent tariff announcements, and continues to focus on non-cyclical industries.
Dividend Policy: Crescent Capital BDC declared a regular dividend of $0.42 per share for Q2 2025, maintaining a consistent dividend history while prioritizing NAV stability.
Debt Management: The company rightsized its SPV asset facility from $500 million to $400 million, reducing the spread by 50 basis points, which enhances its capacity to manage unfunded commitments.
Net Investment Income: The company reported net investment income of $16.6 million or $0.45 per share for Q1 2025, with expectations that this reflects a near-term earnings baseline.
Future Deployment: Crescent Capital BDC anticipates continued attractive investment opportunities despite market volatility, with a focus on maintaining a diversified portfolio.
Leverage Ratio: The debt to equity ratio increased to 1.25 times, within the target leverage range of 1.1 to 1.3 times.
Dividend Outlook: The company expects to maintain its dividend framework, with a special cash dividend of $0.05 per share planned for June 2025.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Regular Dividend: Declared a second quarter 2025 regular dividend of $0.42 per share, payable on July 15, 2025.
Special Dividend: Second in a series of three previously announced special dividends of $0.05 per share, payable on June 13, 2025.
Dividend History: This marks the 37th consecutive quarter of earning the regular dividend.
Dividend Policy: Prioritized consistency and NAV stability over high dividend yield.
Share Repurchase Program: None
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Does the mark for New Era Technology reflect the restructuring that was recently announced for that company?
A:The mark is in line with where we expect to ultimately restructure that name, reflective of the latest view on the earnings outlook.
Q:Is New Era Technology a non-traditional deal for you?
A:New Era has not yet restructured, and we can take it offline to clarify.
Q:What is Crescent’s approach to working toward a resolution with non-accruals?
A:Crescent’s approach is to preserve capital, potentially partner with private equity sponsors, or consider alternatives like selling the company or restructuring.
Q:How much of the portfolio has been Crescent led or originated deals?
A:About 8% of the total fair value is acquired assets; the remaining 92% are loans acquired from First Eagle or Alcentra.
Q:What was the driver of the big sequential decline in Logan's dividend?
A:The decline was due to a timing mismatch in cash distributions related to the equity tranche and the end of the reinvestment period.
Q:Did the cash flows within Logan drop materially?
A:Yes, the overall holdings did not change materially, but cash flows were retained due to overcollateralization tests.
Q:Were there any warning signs for the new non-accruals?
A:The non-accruals were prior watch list names, and there were developments at the respective borrowers that warranted the classification.
Q:Are any of the non-accrual assets still paying cash interest?
A:Let us get back to you and take that offline.
Q:Is there a reckoning in the software sector?
A:There are company-specific drivers rather than broad issues across the software space.
Q:Were there any additional headwinds with timing of fundings or spread compression?
A:The average portfolio was net up, and spreads for new investments were actually higher than in previous quarters.
Q:What is your outlook for spreads given the influx of capital into the market?
A:The influx is significant, putting pressure on spreads, but we are seeing activity in lower and core markets.
Q:Is the Board considering stock buybacks given the current discount?
A:We continue to evaluate buybacks, mindful of the portfolio size and leverage profile.
Q:Review of Unclear Management Responses
A:Management avoided giving a direct answer regarding whether any of the non-accrual assets are still paying cash interest, stating they would take it offline.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
CLO
Day announcement
Liberation Day
Logan JV
NII decline
NII driver
SPV
ability price
approach
beginning
business material
change base
component
detail
dividend income
driver change
effect
end reinvestment
expectation
exposure
facility
good
impact
income Logan
note tranche
rate investment
reinvestment period
review
runoff
selectivity
service business
stability
supplier
tariff announcement
time
view
volatility
CCAP Transcript
Crescent Capital BDC, Inc. (NASDAQ:CCAP) Q1 2025 Earnings Call Transcript
Unknown5-16
The earnings call highlights several concerns: declining net investment income, increased loans on non-accrual, and a higher debt-to-equity ratio. The Q&A reveals management's evasive responses on non-accrual assets and restructuring, indicating uncertainty. Despite consistent dividends, the lack of a share repurchase program and overall market pressure on spreads contribute to a negative sentiment. These factors suggest a negative stock price reaction in the short term.
Crescent Capital BDC, Inc. (CCAP) Q3 2024 Earnings Call Transcript
Unknown11-12
The earnings call presents a mixed picture. Financial performance shows positive signs with increased NII and total investment income, but a slight decrease in NAV and unrealized losses impact GAAP EPS. The shareholder return plan is positive with dividends. However, management's vague responses in the Q&A raise uncertainties, particularly regarding asset rotation and future activity levels. The positive financial metrics are counterbalanced by these uncertainties, leading to a neutral stock price prediction.
Crescent Capital BDC, Inc. (CCAP) Q2 2024 Earnings Call Transcript
Neutral8-13
Crescent Capital BDC, Inc. (CCAP) Q1 2024 Earnings Call Transcript
Neutral5-9
CCAP Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
